Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1258
result was found. Results that relate to
2
Data mining for hypertension associated with VEGFR-TKIs: based on FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1201-1208.
2595 times
754 times
Xiao-Lan LIAO
Jia-Qi GE
Hai-Bin ZHU
Ting-Ting WU
Chun-Xia REN
Zi-Cheng YU
Vascular endothelial growth factor receptor-tyrosine kinase inhibitors
Hypertension
Adverse drug events
Pharmacovigilance
FAERS database
Details
Clinical practice guidelines for the use of intravenous polymyxins in children: a protocol
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1231-1237.
1976 times
674 times
Lin TANG
Shan SHEN
Dong-Na ZOU
Bing LENG
Rui-Fang NIE
Yan JIN
Li-Kai LIN
Xian-Tao ZENG
Suo-Di ZHAI
Ling-Li ZHANG
Ning HOU
Polymyxins
Pediatric medication
Anti-infection
Guideline protocol
Details
A retrospective study of potential drug-drug interactions of dabigatran etexilate in a tertiary hospital
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1243-1249.
2092 times
636 times
An-Hua WEI
Wen-Jing LI
Yan HUANG
Dabigatran etexilate
Potential drug-drug interactions
Safety
Retrospective study
Details
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1259-1266.
2344 times
735 times
Xi ZHAO
Xi YAN
Ning LI
Chun-Xia HOU
Abemaciclib
Fulvestrant
Hormone receptor-positive breast cancer
Markov model
Cost-effectiveness analysis
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1275-1284.
2224 times
663 times
Ya-Ping NIU
San-Bao CHAI
Jing-Zi MA
Meng ZHANG
Zuo-Xiang LIU
Shan-Shan WU
Feng SUN
Basal insulin
Oral hypoglycemic agents
Type 2 diabetes mellitus
Poor treatment effect
Umbrella review
Details
Analysis of clinical features of tacrolimus induced acute pancreatitis based on literature cases
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1285-1295.
2062 times
1198 times
Chao YE
Xin LI
Li-Hua LIU
Xin HE
Shen-Jue CHEN
Juan WANG
Tacrolimus
Acute pancreatitis
Case report
Adverse drug reactions
Literature analysis
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):19-27.
1888 times
1066 times
ZHANG Yinan
WU Tingxi
ZHAO Zhigang
Drug benefit-risk communication
Safety communication
Drug safety information
Pharmacovigilance
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1311-1315.
2318 times
699 times
Jin-Jin ZOU
Ji-Liang ZHANG
Ni LI
Ding-Yi LIU
Pembrolizumab
Lung squamous cell carcinoma
Severe immune-related ulcerative colitis
Adverse drug reactions
Details
A case of sudden cardio arrest caused by oxaliplatin injection
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1316-1320.
2223 times
821 times
Ying WANG
Qin-Yong SHEN
Shan HUANG
Bing LIN
Ai-Wen HUANG
Oxaliplatin
Sudden cardio arrest
Allergic reaction
Adverse drug reaction
Details
Pharmaceutical practice of clinical pharmacists participating in the treatment for refractory edema secondary to diabetic kidney disease
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1425-1431.
1882 times
964 times
Ze CHEN
Wei TIAN
Qi JIN
Xian-Xi GUO
Hua HU
Clinical pharmacist
Drug treatment
Diabetic kidney disease
Refractory edema
Pharmaceutical care
Details
Literature case analysis of hyperammonemic encephalopathy caused by sodium valproate
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1417-1424.
1934 times
577 times
Li-Yuan WANG
Jing LI
Zi-Hao DUAN
Fa-Cai WANG
Jun-Jie JIANG
Sodium valproate
Hyperammonemic encephalopathy
Adverse drug reactions
Case analysis
Details
Cost-utility analysis of azacitidine versus decitabine in the treatment of myelodysplastic syndrome
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1371-1379.
1955 times
667 times
La-Ji DANZENG
Yong-Gong YANG
Si-Liang WANG
Meng-Ying LIU
Azacitidine
Decitabine
Myelodysplastic syndrome
Markov model
Cost-utility analysis
Pharmacoeconomics
Details
Review and risk information management of neuropathy induced by emerging anti-tumor drugs
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):9-18.
2055 times
631 times
LYU Feng
SONG Wei
XIN Mengru
XIE Di
ZHANG Wenqing
HE Wen
HU Hankun
Emerging anti-tumor drugs
Drug-induced neuropathy
Drug risk information management
Details
Case analysis of abnormal increase in blood glucose after targeted combination chemotherapy in a patient with colon cancer
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(2):230-235.
2507 times
1497 times
WU Yan
WANG Xin
Diabetic ketoacidosis
High blood sugar
Fluorouracil
Bevacizumab
Details
Observation of the therapeutic effect of Liuwei Dihuang decoction on thrombocytopenia of liver and kidney yin deficiency in hemodialysis patients
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1354-1361.
2257 times
944 times
Rong CAO
Hua-Juan WEI
Shan-Shan SUN
Na QIN
Wei-Hua LIU
Li-Yan SUN
Liuwei Dihuang decoction
Hemodialysis
Liver and kidney Yin deficiency
Thrombocytopenia
Clinical efficacy
Platelet count
Details
上一页
1
2
27
28
29
30
31
32
33
83
84
下一页
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University